Jim Cramer has built a strong reputation in the industry. He’s the Mad Money host who carefully picks growth stocks that have ...
Pfizer ( PFE +0.24%) pays a dividend that yields around 6.8%. While the yield has been pushed higher as share prices have ...
Celcuity Inc. soared on best-in-class Phase 3 breast cancer data. Click to see why I have a Buy rating on CELC due to data, ...
TipRanks on MSN
Telescope Innovations posts higher 2025 revenue as automation and chemical technologies gain commercial traction
Telescope Innovations Corp ( ($TSE:TELI) ) has shared an update. Telescope Innovations reported fiscal 2025 revenues of $5.8 million, up from $4.4 ...
Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...
Nicki Swift on MSN
Travis Kelce supposedly made a fortune from his Pfizer commercial
Between heading to the Super Bowl and spending time with Taylor Swift, Travis Kelce is everywhere. Maybe that's why his Pfizer ad payday is raising eybrows.
Shanghai Fosun Pharmaceutical is one of China's largest pharmaceutical companies. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) In its latest agreement with a China ...
A Chinese national flag decorates the Erzsebet Bridge in Budapest, Hungary on May 8, 2024. China has approved 19 innovative medicines — including major treatments from Eli Lilly, Pfizer, and Johnson & ...
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy. By Francesca Regalado The obesity drug developer ...
Pfizer has axed 11 programs including two pipeline assets from its $43 billion Seagen acquisition, work on a BioNTech-partnered mRNA vaccine and a midstage metabolic dysfunction-associated ...
Pfizer Inc. secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry Tuesday by agreeing to slash some of its drug prices by up to 85% and selling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results